natgillin/translations-raw huggingface dataset:
Olanzapine Teva 5 mg film-coated tablets EU/1/07/427/004 - 28 tablets, per box EU/1/07/427/070 - 28 x 1 tablets, per box EU/1/07/427/005 - 30 tablets, per box EU/1/07/427/071 - 30 x 1 tablets, per box EU/1/07/427/039 - 35 tablets, per box EU/1/07/427/072 - 35 x 1 tablets, per box EU/1/07/427/006 - 50 tablets, per box EU/1/07/427/073 - 50 x 1 tablets, per box EU/1/07/427/007 - 56 tablets, per box EU/1/07/427/074 - 56 x 1 tablets, per box EU/1/07/427/049 - 70 tablets, per box EU/1/07/427/075 - 70 x 1 tablets, per box EU/1/07/427/059 - 98 tablets, per box EU/1/07/427/076 - 98 x 1 tablets, per box
Olanzapin Teva 5 mg filmsko obložene tablete EU/1/07/427/004 - 28 tablet v škatli EU/1/07/427/070 - 28 x 1 tableta v škatli EU/1/07/427/005 - 30 tablet v škatli EU/1/07/427/071 - 30 x 1 tableta v škatli EU/1/07/427/039 - 35 tablet v škatli EU/1/07/427/072 - 35 x 1 tableta v škatli EU/1/07/427/006 - 50 tablet v škatli EU/1/07/427/073 - 50 x 1 tableta v škatli EU/1/07/427/007 - 56 tablet v škatli EU/1/07/427/074 - 56 x 1 tableta v škatli EU/1/07/427/049 - 70 tablet v škatli EU/1/07/427/075 - 70 x 1 tableta v škatli EU/1/07/427/059 - 98 tablet v škatli EU/1/07/427/076 - 98 x 1 tableta v škatli
7 film-coated tablets 7 x 1 film-coated tablets 28 film-coated tablets 28 x 1 film-coated tablets 30 film-coated tablets 30 x 1 film-coated tablets 35 film-coated tablets 35 x 1 film-coated tablets 50 film-coated tablets 50 x 1 film-coated tablets 56 film-coated tablets 56 x 1 film-coated tablets 60 film-coated tablets 70 film-coated tablets 70 x 1 film-coated tablets 98 film-coated tablets 98 x 1 film-coated tablets
7 filmsko obloženih tablet 7 x 1 filmsko obložena tableta 28 filmsko obloženih tablet 28 x 1 filmsko obložena tableta 30 filmsko obloženih tablet 30 x 1 filmsko obložena tableta 35 filmsko obloženih tablet 35 x 1 filmsko obložena tableta 50 filmsko obloženih tablet 50 x 1 filmsko obložena tableta 56 filmsko obloženih tablet 56 x 1 filmsko obložena tableta 70 filmsko obloženih tablet 70 x 1 filmsko obložena tableta 98 filmsko obloženih tablet 98 x 1 filmsko obložena tableta
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains: 7.5 mg Olanzapine.
Ena filmsko obložena tableta vsebuje: 7,5 mg olanzapina.
Olanzapine Teva 10 mg film-coated tablets
Olanzapin Teva 10 mg filmsko obložene tablete
Each Olanzapine Teva 5 mg film-coated tablet contains 5 mg of the active substance.
Ena Olanzapin Teva 5 mg filmsko obložena tableta vsebuje 5 mg učinkovine.
Changes in total fasting cholesterol levels from borderline at baseline (≥4.39-<5.17 mmol/l) to high (≥5.17 mmol/l) were very common.
15 Pogosto so opazovali spremembe v ravneh celokupnega holesterola na tešče z normalnih osnovnih vrednosti (< 4,39 mmol/l), ki so se povišale na visoke (≥ 5,17 mmol/l).
Hydroxypropylcellulose
Obloga tablete hipromeloza
Olanzapine Teva 15 mg orodispersible tablets A yellow, round, biconvex tablet, with 11 mm of diameter.
Olanzapin Teva 15 mg orodisperzibilne tablete Rumena, okrogla, bikonveksna tableta, premera 11 mm.
Olanzapine Teva 2.5 mg film-coated tablets are available in cartons of 28, 30, 35, 56, 70 or 98 filmcoated tablets.
Olanzapin Teva 2,5 mg filmsko obložene tablete so na voljo v pakiranjih po 28, 30, 35, 56, 70 ali 98 filmsko obloženih tablet.
Each orodispersible tablet contains 10 mg olanzapine.
Ena orodisperzibilna tableta vsebuje: 10 mg olanzapina.
Olanzapine Teva 5 mg film-coated tablets
Olanzapin Teva 5 mg filmsko obložene tablete
Olanzapine Teva 2.5 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed ”OL 2.5” on one side and plain on the other.
Olanzapin Teva 2,5 mg filmsko obložena tableta je bela, bikonveksna, okrogla filmsko obložena tableta z vtisnjenim napisom »OL 2,5« na eni strani in ravna na drugi strani.
Each Olanzapine Teva 15 mg film-coated tablet contains 15 mg of the active substance.
Ena Olanzapin Teva 15 mg filmsko obložena tableta vsebuje 15 mg učinkovine.
Olanzapine Teva 20 mg orodispersible tablet is a yellow, round, biconvex tablet, with 12 mm of diameter.
Olanzapin Teva 20 mg orodisperzibilna tableta je rumena, okrogla, bikonveksna tableta, premera 12 mm.
Olanzapine Teva 20 mg orodispersible tablets A yellow, round, biconvex tablet, with 12 mm of diameter.
Olanzapin Teva 20 mg orodisperzibilne tablete Rumena, okrogla, bikonveksna tableta, premera 12 mm.
Olanzapine Teva 15 mg orodispersible tablet is a yellow, round, biconvex tablet, with 11 mm of diameter.
Olanzapin Teva 15 mg orodisperzibilna tableta je rumena, okrogla, bikonveksna tableta, premera 11 mm.
28 film-coated tablets 30 film-coated tablets 35 film-coated tablets 50 film-coated tablets 56 film-coated tablets 70 film-coated tablets 98 film-coated tablets
28 filmsko obloženih tablet 30 filmsko obloženih tablet 35 filmsko obloženih tablet 50 filmsko obloženih tablet 56 filmsko obloženih tablet 70 filmsko obloženih tablet 98 filmsko obloženih tablet
EU/1/07/427/029 - 50 tablets, per box
EU/1/07/427/029 - 50 tablet v škatli
Olanzapine Teva 5 mg orodispersible tablets EU/1/07/427/023 - 28 tablets, per box
Olanzapin Teva 5 mg orodisperzibilne tablete EU/1/07/427/023 - 28 tablet v škatli
Olanzapine Teva 10 mg film-coated tablets EU/1/07/427/011 - 7 tablets, per box EU/1/07/427/083 - 7 x 1 tablets, per box EU/1/07/427/012 - 28 tablets, per box EU/1/07/427/084 - 28 x 1 tablets, per box EU/1/07/427/013 - 30 tablets, per box EU/1/07/427/085 - 30 x 1 tablets, per box EU/1/07/427/041 - 35 tablets, per box EU/1/07/427/086 - 35 x 1 tablets, per box EU/1/07/427/014 - 50 tablets, per box EU/1/07/427/087 - 50 x 1 tablets, per box EU/1/07/427/015 - 56 tablets, per box EU/1/07/427/088 - 56 x 1 tablets, per box EU/1/07/427/069 - 60 tablets, per box EU/1/07/427/051 - 70 tablets, per box EU/1/07/427/089 - 70 x 1 tablets, per box EU/1/07/427/061 - 98 tablets, per box EU/1/07/427/090 - 98 x 1 tablets, per box
Olanzapin Teva 10 mg filmsko obložene tablete EU/1/07/427/011 - 7 tablet v škatli EU/1/07/427/083 - 7 x 1 tableta v škatli EU/1/07/427/012 - 28 tablet v škatli EU/1/07/427/084 - 28 x 1 tableta v škatli EU/1/07/427/013 - 30 tablet v škatli EU/1/07/427/085 - 30 x 1 tableta v škatli EU/1/07/427/041 - 35 tablet v škatli EU/1/07/427/086 - 35 x 1 tableta v škatli EU/1/07/427/014 - 50 tablet v škatli EU/1/07/427/087 - 50 x 1 tableta v škatli EU/1/07/427/015 - 56 tablet v škatli EU/1/07/427/088 - 56 x 1 tableta v škatli EU/1/07/427/069 - 60 tablet v škatli EU/1/07/427/051 - 70 tablet v škatli
Olanzapine Teva 10 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed ”OL 10” on one side and plain on the other.
Olanzapin Teva 10 mg filmsko obložena tableta je bela, bikonveksna, okrogla filmsko obložena tableta z vtisnjenim napisom »OL 10« na eni strani in ravna na drugi strani.
Olanzapine Teva 15 mg film-coated tablet is a light blue, biconvex, oval film-coated tablet, debossed ”OL 15” on one side and plain on the other.
Olanzapin Teva 15 mg filmsko obložena tableta je svetlo modra, bikonveksna, ovalna filmsko obložena tableta z vtisnjenim napisom »OL 15« na eni strani in ravna na drugi strani.
EU/1/07/427/017 - 30 tablets, per box
EU/1/07/427/017 - 30 tablet v škatli
OPA-Al-PVC/Al blisters in cartons of 28, 30, 35, 50, 56, 70 or 98 orodispersible tablets per carton.
OPA-aluminij-PVC/aluminij pretisni omoti v škatlah po 28, 30, 35, 50, 56, 70 ali 98 orodisperzibilnih tablet.
13 Following short term treatment (median duration 22 days), weight gain ≥7% of baseline body weight (kg) was very common (40.6%), ≥15% of baseline body weight was common (7.1%) and ≥25% was common (2.5%).
od osnovne telesne mase (kg) je bilo zelo pogosto (40,6 %), ≥ 15 % pogosto (7,1 %) in za ≥ 25 %
EU/1/07/427/048 - 70 tablets, per box
EU/1/07/427/048 - 70 tablet v škatli
Thromboembolism Temporal association of olanzapine treatment and venous thromboembolism has been reported uncommonly (≥0.1% and <1%).
Občasno ( ≥ 0,1 % in < 1 %) so poročali o občasnih povezavah med zdravljenjem z olanzapinom in vensko tromboembolijo.
Olanzapine Teva 10 mg orodispersible tablets A yellow, round, biconvex tablet with 10 mm of diameter.
Olanzapin Teva 10 mg orodisperzibilne tablete Rumena, okrogla, bikonveksna tableta, premera 10 mm.
EU/1/07/427/022 - 56 tablets, per box
EU/1/07/427/022 - 56 tablet v škatli
EU/1/07/427/018 - 50 tablets, per box
EU/1/07/427/018 - 50 tablet v škatli
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains: 2.5 mg Olanzapine.
Ena filmsko obložena tableta vsebuje: 2,5 mg olanzapina.
Olanzapine Teva 5 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed ”OL 5” on one side and plain on the other.
Olanzapin Teva 5 mg filmsko obložena tableta je bela, bikonveksna, okrogla filmsko obložena tableta z vtisnjenim napisom »OL 5« na eni strani in ravna na drugi strani.
Olanzapine Teva 10 mg orodispersible tablets EU/1/07/427/027 - 28 tablets, per box
Olanzapin Teva 10 mg orodisperzibilne tablete EU/1/07/427/027 - 28 tablet v škatli
- Moderate to severe manic episodes, a condition with symptoms of excitement or euphoria.
Ljudje s to boleznijo se lahko počutijo tudi depresivno, občutijo tesnobo ali napetost; - zmernih do resnejših maničnih epizod, bolezni s simptomi razburjenja ali evforije.
Neutropenia10
Trombocitopenija11
EU/1/07/427/028 - 30 tablets, per box
EU/1/07/427/028 - 30 tablet v škatli
Olanzapine Teva 15 mg orodispersible tablets EU/1/07/427/031 - 28 tablets, per box
Olanzapin Teva 15 mg orodisperzibilne tablete EU/1/07/427/031 - 28 tablet v škatli
EU/1/07/427/052 - 70 tablets, per box EU/1/07/427/062 - 98 tablets, per box
EU/1/07/427/089 - 70 x 1 tableta v škatli EU/1/07/427/061 - 98 tablet v škatli EU/1/07/427/090 - 98 x 1 tableta v škatli
28 film-coated tablets 28 x 1 film-coated tablets 30 film-coated tablets 30 x 1 film-coated tablets 35 film-coated tablets 35 x 1 film-coated tablets 50 film-coated tablets 50 x 1 film-coated tablets 56 film-coated tablets 56 x 1 film-coated tablets 70 film-coated tablets 70 x 1 film-coated tablets 98 film-coated tablets 98 x 1 film-coated tablets
28 filmsko obloženih tablet 28 x 1 filmsko obložena tableta 30 filmsko obloženih tablet 30 x 1 filmsko obložena tableta 35 filmsko obloženih tablet 35 x 1 filmsko obložena tableta 50 filmsko obloženih tablet 50 x 1 filmsko obložena tableta 56 filmsko obloženih tablet 56 x 1 filmsko obložena tableta 70 filmsko obloženih tablet 70 x 1 filmsko obložena tableta 98 filmsko obloženih tablet 98 x 1 filmsko obložena tableta
OPA-Al-PVC/Al blisters in cartons of 28, 30, 35, 56, 70 or 98 orodispersible tablets per carton.
OPA-aluminij-PVC/aluminij pretisni omoti v škatlah po 28, 30, 35, 56, 70 ali 98 orodisperzibilnih tablet.
Olanzapine Teva 20 mg film-coated tablets are available in cartons of 28, 30, 35, 56, 70 or 98 filmcoated tablets.
Olanzapin Teva 20 mg filmsko obložene tablete so na voljo v pakiranjih po 28, 30, 35, 56, 70 ali 98 filmsko obloženih tablet.
EU/1/07/427/058 - 98 tablets, per box
EU/1/07/427/058 - 98 tablet v škatli
EU/1/07/427/026 - 56 tablets, per box
EU/1/07/427/026 - 56 tablet v škatli
EU/1/07/427/036 - 30 tablets, per box
EU/1/07/427/036 - 30 tablet v škatli
EU/1/07/427/038 - 35 tablets, per box
EU/1/07/427/038 - 35 tablet v škatli
EU/1/07/427/019 - 56 tablets, per box
EU/1/07/427/019 - 56 tablet v škatli
(≥1.69 mmol/l-<2.26 mmol/l) to high (≥2.26 mmol/l) were very common.
Zelo pogoste so bile spremembe v ravneh trigliceridov na tešče z mejnih osnovnih vrednosti (≥ 1,69 mmol/l - < 2,26 mmol/l) na visoke (≥ 2,26 mmol/l).
EU/1/07/427/033 - 50 tablets, per box
EU/1/07/427/033 - 50 tablet v škatli
Glutamyltransfera se10
Visoka raven gamaglutamiltransferaze10
EU/1/07/427/032 - 30 tablets, per box
EU/1/07/427/032 - 30 tablet v škatli
EU/1/07/427/021 - 30 tablets, per box
EU/1/07/427/021 - 30 tablet v škatli
Olanzapine Teva 5 mg film-coated tablets are available in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 or 98 x 1 film-coated tablets.
Olanzapin Teva 5 mg filmsko obložene tablete so na voljo v pakiranjih po 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 ali 98 x 1 filmsko obložena tableta.
EU/1/07/427/055 - 70 tablets, per box
EU/1/07/427/055 - 70 tablet v škatli
Olanzapine Teva 10 mg film-coated tablets are available in cartons of 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x1 film-coated tablets.
Olanzapin Teva 10 mg filmsko obložene tablete so na voljo v pakiranjih po 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 ali 98 x 1 filmsko obložena tableta.
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 7.5 mg film-coated tablets Olanzapine
Olanzapin Teva 7,5 mg filmsko obložene tablete olanzapin
EU/1/07/427/042 - 35 tablets, per box
EU/1/07/427/042 - 35 tablet v škatli
High uric acid10
Visoka raven sečne kisline10
EU/1/07/427/025 - 50 tablets, per box
EU/1/07/427/025 - 50 tablet v škatli
EU/1/07/427/002 - 30 tablets, per box
EU/1/07/427/002 - 30 tablet v škatli
14 Observed for fasting normal levels at baseline (<1.016 mmol/l) which increased to high
14 Opazovano pri osnovnih normalnih ravneh na tešče (< 1,016 mmol/l), ki so se povišale na visoke (≥ 1,467 mmol/l) in spremembe v ravneh trigliceridov na tešče z mejnih osnovnih vrednosti
EU/1/07/427/053 - 70 tablets, per box
EU/1/07/427/053 - 70 tablet v škatli
EU/1/07/427/030 - 56 tablets, per box
EU/1/07/427/030 - 56 tablet v škatli
EU/1/07/427/056 - 70 tablets, per box
EU/1/07/427/056 - 70 tablet v škatli
EU/1/07/427/003 - 56 tablets, per box
EU/1/07/427/003 - 56 tablet v škatli
EU/1/07/427/054 - 70 tablets, per box
EU/1/07/427/054 - 70 tablet v škatli
The following symptoms may occur in newborn babies, of mothers that have used Olanzapine Teva in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding.
se lahko pojavijo naslednji simptomi: tresenje, okornost ali šibkost mišic, zaspanost, nemir, težave z dihanjem in motnje hranjenja.
EU/1/07/427/024 - 30 tablets, per box
EU/1/07/427/024 - 30 tablet v škatli
Olanzapine Teva 7.5 mg film-coated tablets are available in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x 1 film-coated tablets.
Olanzapin Teva 7,5 mg filmsko obložene tablete so na voljo v pakiranjih po 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 ali 98 x 1 filmsko obložena tableta.
OPA/alu/PVC-alu blisters in cartons of 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x 1 film-coated tablets per carton.
OPA/aluminij/PVC aluminij pretisni omoti v škatlah po 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 ali 98 x 1 filmsko obložena tableta.
EU/1/07/427/043 - 35 tablets, per box
EU/1/07/427/043 - 35 tablet v škatli
EU/1/07/427/037 - 56 tablets, per box
EU/1/07/427/037 - 56 tablet v škatli
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 2.5 mg film-coated tablets Olanzapine
Olanzapin Teva 2,5 mg filmsko obložene tablete olanzapin
Weight should be monitored regularly, e.g. at baseline, 4, 8 and 12 weeks after starting olanzapine treatment and quarterly thereafter.
Redno moramo spremljati telesno maso, npr. na začetku, 4, 8 in
OPA/alu/PVC-alu blisters in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 or 98 x 1 film-coated tablets per carton.
OPA/aluminij/PVC aluminij pretisni omoti v škatlah po 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 ali 98 x 1 filmsko obložena tableta.
EU/1/07/427/034 - 56 tablets, per box
EU/1/07/427/034 - 56 tablet v škatli
(≥5.17-<6.2 mmol/l) to high (≥6.2 mmol/l) were very common.
- < 5,17 mmol/l) na visoke (≥ 5,17 mmol/l).
OPA/alu/PVC-alu blisters in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x 1 film-coated tablets per carton.
OPA/aluminij/PVC aluminij pretisni omoti v škatlah po 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 ali 98 x 1 filmsko obložena tableta.
EU/1/07/427/065 - 98 tablets, per box
EU/1/07/427/065 - 98 tablet v škatli
EU/1/07/427/046 - 35 tablets, per box
EU/1/07/427/046 - 35 tablet v škatli
EU/1/07/427/067 - 98 tablets, per box
EU/1/07/427/067 - 98 tablet v škatli
NAME OF THE MEDICINAL PRODUCT Olanzapine Teva 20 mg film-coated tablets Olanzapine
Olanzapin Teva 20 mg filmsko obložene tablete olanzapin
EU/1/07/427/064 - 98 tablets, per box
EU/1/07/427/064 - 98 tablet v škatli
EU/1/07/427/057 - 70 tablets, per box
EU/1/07/427/057 - 70 tablet v škatli
EU/1/07/427/066 - 98 tablets, per box
EU/1/07/427/066 - 98 tablet v škatli
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains: 20 mg Olanzapine.
Ena filmsko obložena tableta vsebuje: 20 mg olanzapina.
EU/1/07/427/045 - 35 tablets, per box
EU/1/07/427/045 - 35 tablet v škatli
EU/1/07/427/063 - 98 tablets, per box
EU/1/07/427/063 - 98 tablet v škatli
EU/1/07/427/047 - 35 tablets, per box
EU/1/07/427/047 - 35 tablet v škatli
Musculoskeletal and connective tissue disorders Arthralgia9
Bolezni mišično-skeletnega sistema in vezivnega tkiva
Respiratory, thoracic and mediastinal disorders Epistaxis9
Bolezni dihal, prsnega koša in mediastinalnega prostora
Olanzapine Teva 15 mg film-coated tablets OPA/alu/PVC-alu blisters in cartons of 28, 30, 35, 50, 56, 70 or 98 film-coated tablets per carton.
OPA/aluminij/PVC aluminij pretisni omoti v škatlah po 28, 30, 35, 56, 70 ali 98 filmsko obloženih tablet.
EU/1/07/427/044 - 35 tablets, per box
EU/1/07/427/044 - 35 tablet v škatli
Olanzapine Teva 20 mg film-coated tablets Pink, biconvex, oval film-coated tablets, debossed ”OL 20” on one side and plain on the other.
Roza, bikonveksne, ovalne filmsko obložene tablete z vtisnjenim napisom »OL 20« na eni strani in ravne na drugi strani.
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains: 10 mg Olanzapine.
Ena filmsko obložena tableta vsebuje: 10 mg olanzapina.
Olanzapine Teva 7.5 mg film-coated tablets White, biconvex, round film-coated tablets, debossed ”OL 7.5” on one side and plain on the other.
Bele, bikonveksne, okrogle filmsko obložene tablete z vtisnjenim napisom »OL 7,5« na eni strani in ravne na drugi strani.
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains: 5 mg Olanzapine.
Ena filmsko obložena tableta vsebuje: 5 mg olanzapina.
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains: 15 mg Olanzapine.
Ena filmsko obložena tableta vsebuje: 15 mg olanzapina.
Fatigue
Zaspanost
Belgium Factane 1000 IU/10 ml
Factane 1000 i.e./10 ml
Belgium Factane 500 IU - 5 ml
Factane 500 i.e. - 5 ml
Powder For Solution For Injection
Prašek za injekcijo
LFB Biomedicaments Human Coagulation Factor VIII
LFB Biomedicaments Humani koagulacijski faktor VIII
Human Coagulation Factor VIII 250 I.E.
Humani koagulacijski faktor VIII 250 i.e.
Human Coagulation Factor VIII 1000 I.E.
Humani koagulacijski faktor VIII 1000 i.e.
Human Coagulation Factor VIII 1500 I.E.
Humani koagulacijski faktor VIII 1500 i.e.
Human Coagulation Factor VIII 2000 IU
Humani koagulacijski faktor VIII 2000 i.e.
Human Coagulation Factor VIII 1000 I.E. Human Von Willebrand Factor 2400 I.E.
Humani koagulacijski faktor VIII 1000 i.e. humani von Willebrandov faktor 2400 i.e. VIII
Human Coagulation Factor VIII 500 I.E.
Humani koagulacijski faktor VIII 500 i.e.
Human Coagulation Factor VIII 1000IU/Vial, Human Von Willebrand Factor 75 I.U.
Humani koagulacijski faktor VIII 1000 i.e./viala, humani von Willebrandov faktor 75 i.e. /ml
Human Coagulation Factor VIII 500 I.E., Human Von Willebrand Factor 1200 I.E.
Humani koagulacijski faktor VIII 500 i.e., humani von Willebrandov faktor 1200 i.e.
Human Coagulation Factor VIII 250 I.E. Human Von Willebrand Factor 150 I.E.
Humani koagulacijski faktor VIII 250 i.e., humani von Willebrandov faktor 150 i.e.
Human Coagulation Factor VIII 500 I.E., Human Von Willebrand Factor 300 I.E.
Humani koagulacijski faktor VIII 500 i.e., humani von Willebrandov faktor 300 i.e.
Human Coagulation Factor VIII 250 I.E., Human Von Willebrand Factor 600 I.E.
Humani koagulacijski faktor VIII 250 i.e., humani von Willebrandov faktor 600 i.e.
Human Coagulation Factor VIII (Rdna) 200 I.U.
Humani koagulacijski faktor VIII (rDNA) 200 i.e. /ml
Human Coagulation Factor VIII 1000 I.E./ Human Von Willebrand Factor 600 I.E.
Humani koagulacijski faktor VIII 1000 i.e., humani von Willebrandov faktor 600 i.e. VIII
Human Coagulation Factor VIII (Rdna) 500IU/Vial
Humani koagulacijski faktor VIII (rDNA) 500 i.e./viala
Powder And Solvent For Solution For Infusion
Prašek in vehikel za raztopino za infundiranje
Human Coagulation Factor VIII (Rdna) 1000IU/Vial
Humani koagulacijski faktor VIII (rDNA) 1000 i.e./viala
Csl Behring Gmbh Human Coagulation Factor VIII (Rdna),
Csl Behring Gmbh Humani koagulacijski faktor VIII (rDNA), humani von
United Kingdom Optivate
Združeno kraljestvo
Human Coagulation Factor VIII (Rdna) 100 I.U.
Humani koagulacijski faktor VIII (rDNA) 100 i.e. /ml
Human Coagulation Factor VIII (Rdna) 50 I.U.
Humani koagulacijski faktor VIII (rDNA) 50 i.e. /ml
Human Coagulation Factor VIII (Rdna) 1000 I.U.
Humani koagulacijski faktor VIII (rDNA) 1000 i.e. Viala
Haemate P Csl Behring Gmbh Human Coagulation Factor VIII (Rdna),
Haemate P Csl Behring Gmbh Humani koagulacijski faktor VIII (rDNA), humani von
Human Coagulation Factor VIII (Rdna) 250IU/Vial
Humani koagulacijski faktor VIII (rDNA) 250 i.e./viala
Human Coagulation Factor VIII (Rdna) 25 I.U.
Humani koagulacijski faktor VIII (rDNA) 25 i.e. /ml
Human Coagulation Factor VIII (Rdna) 500 I.U.
Humani koagulacijski faktor VIII (rDNA) 500 i.e. Viala
Human Coagulation Factor VIII (Rdna) 250 I.U.
Humani koagulacijski faktor VIII (rDNA) 250 i.e. Viala
Human Coagulation Factor VIII 100 I.U./ml, Human Von Willebrand Factor 100 I.U./mlVIII
Humani koagulacijski faktor VIII (rDNA) 50 i.e. /ml, humani von Willebrandov faktor 120 i.e. /ml
Haemate P Csl Behring Gmbh Human Coagulation Factor VIII, Human Von
Haemate P Csl Behring Gmbh Humani koagulacijski faktor VIII, humani von
Human Coagulation Factor VIII 100 I.U./ml, Human Von Willebrand Factor 100 I.U./ml VIII
Humani koagulacijski faktor VIII 100 i.e. /ml, von Willebrandov faktor 25 i.e. /ml
Human Coagulation Factor VIII 500IU/Vial, Human Von Willebrand Factor 120 I.U.
Humani koagulacijski faktor VIII 50 i.e. /ml, von Willebrandov faktor 120 i.e. /ml
Cardboard box 1 vial of freezedried antigen and 1 vial of aqueous adjuvant
Velikost pakiranja zloženka 1 viala liofiliziranega antigena in 1 viala vodnega dodatka
There is no known specific antidote.
Specifičnega znanega antidota ni.
This will help the doctor identify what you have taken.
Tako boste zdravniku pomagali ugotoviti, kaj ste vzeli.
The magnitude of this effect is not considered to be of clinical relevance.
Razsežnost tega učinka ne velja za klinično pomembno.
Overall, it can be concluded that the kidney is not the primary route of excretion.
Na splošno je možno sklepati, da ledvice niso glavna pot izločanja.
Children and adolescents under the age of 18 years must not take this medicine as it has not been studied in these age groups.
Otroci in mladostniki, stari manj kot 18 let, tega zdravila ne smejo jemati, saj ga v teh starostnih skupinah niso preučili.
Elderly (≥ 65 years old)
Starejše osebe (≥65 let)
Symptomatic and supportive treatment should be administered as appropriate.
Uvesti je treba simptomatsko in podporno zdravljenje, kot je ustrezno.
A risk to the newborns/infants cannot be excluded.
Tveganja za novorojence/dojenčke ne moremo izključiti.
Follow the instructions that your doctor has given you.
Upoštevajte navodila, ki ste jih prejeli od zdravnika.
At screening, the mean age was similar in all treatment groups in both studies, ranging between 61.5 and 65.3 years.
Pri presejanju je bila povprečna starost podobna v vseh skupinah zdravljenja v obeh študijah z razponom od 61,5 do 65,3 leta.
Caution must be exercised in patients ≥ 85 years of age as there is limited experience in this age group.
Previdnost je potrebna pri bolnikih, starih ≥ 85 let, saj so izkušnje pri tej starostni skupini omejene.
Date of first authorisation: 24 June 2016
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM Datum prve odobritve: 24. junij 2016